Aerie Pharmaceuticals reported $63.62M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Aerie Pharmaceuticals AERI:US $ 63.62M 95.21M
Alimera Sciences ALIM:US $ 18.78M 0.35M
Amarin AMRN:US $ 110.23M 53.42M
Cara Therapeutics CARA:US $ 3.63M 2.48M
Coherus Biosciences CHRS:US $ 117.04M 5.98M
Endo International Ordinary Shares ENDP:US $ 485.66M 116.38M
Horizon Pharma HZNP:US $ 684.51M 51.73M
Insmed INSM:US $ 25.72M 1.37M
JAZZ PHA JAZZ:US $ 572.39M 9.03M
Merk MRK:US $ 9828M 598M
Mirati Therapeutics MRTX:US $ 1.81M 0.7M
Novartis NOVN:VX 8.68B 395M
Ophthotech OPHT:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 92.1M 4.22M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M
Revance Therapeutics RVNC:US $ 4.47M 1.12M
Supernus Pharmaceuticals SUPN:US $ 145.15M 3.78M
Teva Pharmaceutical Industries TEVA:US $ 4253M 276M
Valeant Pharmaceuticals VRX:CN $ 1566M 209M
Zoetis ZTS:US $ 1222M 89M